(MENAFN- Kashmir Observer) Srinagar- Five years after the onset of the COVID-19 pandemic, China is grappling with an outbreak of the human metapneumovirus (HMPV). Reports and social media posts suggest that the virus is spreading rapidly, with allegations of overwhelmed hospitals and crematories. online videos show overcrowded hospitals, while users claim that multiple viruses - including influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19 - are circulating simultaneously.
Despite the rise in respiratory illnesses, neither the Chinese government nor the World health Organization (WHO) has issued an official warning or declared an emergency.
ADVERTISEMENT
The surge in cases is primarily affecting children and the elderly. Young children with developing immune systems are particularly vulnerable, while older adults and those with pre-existing conditions like asthma or COPD face heightened risks of severe complications. Symptoms resemble those of the flu or a cold, including fever, cough, and runny nose, with some patients experiencing wheezing. Severe cases can lead to bronchitis or pneumonia.
ADVERTISEMENT
Experts attribute this increase in respiratory illnesses, including HMPV, to colder weather and the resumption of normal activities post-Covid-19. Years of strict lockdowns and reduced social interaction had limited the spread of many viruses, leaving people - especially children - less exposed to common pathogens. As social interactions return, many are encountering these viruses for the first time, creating a“catch-up” period.
In response to the rising cases, Business Standard reported that China's disease control authorities are adopting proactive measures.
Read Also
China Plays Down Reports Of Huge Flu Outbreak; Says Country Safe For Travel
Hepatitis-A Cases Among Children Detected In Bandipora Villages
According to Reuters, health officials have launched a pilot system to monitor pneumonia of unknown origin. This initiative is aimed at improving preparedness for respiratory diseases during the winter months. The move contrasts with the country's limited readiness during the initial outbreak of Covid-19.
The National Disease Control and Prevention Administration (NCDPA) has issued protocols requiring laboratories to report cases, while disease control agencies will verify and handle them. Official data indicates an increase in respiratory infections for the week of December 16 to 22.
Kan Biao, an NCDPA official, stated that China is likely to face an uptick in respiratory diseases throughout the winter and spring. However, he noted that the total number of cases this year is expected to be lower than in 2024.
Reports highlight that several respiratory pathogens, including rhinovirus and HMPV, are rising, particularly among children under 14. Northern provinces have seen a notable increase in HMPV cases.
What is Human Metapneumovirus (HMPV)?
Human metapneumovirus (HMPV) is a viral infection that typically leads to symptoms resembling those of the common cold. It often causes upper respiratory infections, though it can sometimes lead to more severe conditions such as pneumonia, asthma flare-ups, or aggravate chronic obstructive pulmonary disease (COPD). HMPV infections are most prevalent during the winter and early spring months.
HMPV is commonly contracted by children before the age of five. Although it is possible to experience HMPV more than once, subsequent infections generally result in milder symptoms.
Symptoms of HMPV infection include a cough, fever, runny or blocked nose, sore throat, wheezing, shortness of breath, and rashes.
HMPV is caused by a virus - a tiny microorganism that invades cells to reproduce. It belongs to the same viral family as those responsible for RSV, measles, and mumps. HMPV spreads primarily through direct contact with infected individuals or surfaces contaminated with the virus. Common modes of transmission include:Coughing and sneezing,Physical contact such as shaking hands, hugging, or kissing, touching contaminated objects or surfaces, such as phones, doorknobs, keyboards, or toys.
Currently, there are no antiviral treatments for HMPV. Most individuals can manage their symptoms at home until recovery.
However, if symptoms are severe, hospitalisation may be required for closer monitoring and to prevent further complications. In such cases, healthcare providers may administer Oxygen therapy to assist with breathing, supplemental oxygen may be provided through a nose tube or mask; IV fluids to help maintain hydration
Or corticosteroids: Steroids may be used to reduce inflammation and alleviate some symptoms.
Follow this link to join our WhatsApp group : Join Now